Found: 11
Select item for more details and to access through your institution.
A Horse, a Jockey, and a Therapeutic Dilemma: Choosing the Best Option for a Patient with Diabetes and Coronary Artery Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 357, doi. 10.1007/s40256-022-00527-8
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 363, doi. 10.1007/s40256-021-00515-4
- By:
- Publication type:
- Article
A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 385, doi. 10.1007/s40256-022-00523-y
- By:
- Publication type:
- Article
Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 395, doi. 10.1007/s40256-021-00516-3
- By:
- Publication type:
- Article
Comparison of Direct Oral Anticoagulants for Acute Hospital Mortality in Venous Thromboembolism.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 407, doi. 10.1007/s40256-021-00514-5
- By:
- Publication type:
- Article
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 417, doi. 10.1007/s40256-021-00519-0
- By:
- Publication type:
- Article
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 425, doi. 10.1007/s40256-021-00520-7
- By:
- Publication type:
- Article
Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 437, doi. 10.1007/s40256-022-00533-w
- By:
- Publication type:
- Article
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 445, doi. 10.1007/s40256-022-00526-9
- By:
- Publication type:
- Article
Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 451, doi. 10.1007/s40256-022-00538-5
- By:
- Publication type:
- Article
Comment on: "A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy".
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 4, p. 461, doi. 10.1007/s40256-022-00539-4
- By:
- Publication type:
- Article